IMAX Corporation (IMAX) Presents at Bank of America 2026 Media,Communications & Entertainment Conference Transcript

IMAX CEO Richard Gelfond said the company is undergoing a “dramatic awakening globally,” following a year in which its stock roughly doubled from a long-standing range near $18 to the $50s. He said IMAX box office is approaching $500 million, compared with its prior record of $225 million for Avatar, despite IMAX representing only about 1% of global cinema screens. Management characterized the current momentum as the beginning of a broader growth opportunity rather than a late-cycle peak.

Analysis

IMAX’s rerating rests on a shift from being a cyclical box-office royalty stream to a scarce premium-format gatekeeper for event films. The key earnings leverage is not aggregate admissions but mix: premium-format demand can lift per-screen revenue and film-rental economics without requiring broad theatrical recovery. That creates a relative advantage versus exhibitors such as AMC (AMC) and Cinemark (CNK), which retain materially higher fixed-cost and concession-demand exposure.

The near-term risk is that investors extrapolate one exceptional premium-format cycle into normalized earnings. Management’s box-office framing is not independently sufficient to establish IMAX revenue, because realized economics depend on retained screen share, local-currency collections in international markets, revenue-sharing terms, and the conversion of demand into installations or system-sales backlog. The next 1-3 month validation points are quarterly network revenue per screen, new-installation signings, and forward premium-screen allocations for major releases; a deceleration in any of those would challenge the multiple expansion.

A second-order beneficiary is Dolby Laboratories (DLB), whose Dolby Cinema footprint competes for the same premium consumer wallet and may gain if studios increasingly reserve enhanced formats for tentpole releases. The contrarian view is that premiumization may be a structural industry response to lower release volume rather than evidence of a broad theatrical demand revival: IMAX can outperform even if domestic box office remains below prior-cycle levels, while traditional exhibitors and advertising-exposed media names do not necessarily participate.

Key Decisions for Investors

• Maintain or initiate a modest long IMAX only on post-earnings confirmation that network revenue per screen and installation backlog are both rising; use a 6-12 month horizon. The thesis is premium-format mix and asset-light operating leverage, not a generalized cinema recovery.
• Express relative premium-format exposure through long IMAX / short CNK in equal dollar beta-adjusted sizing over 3-6 months. This isolates IMAX’s higher-margin licensing/technology model from exhibitor labor, lease, and concession-cost pressure; exit if CNK’s attendance and concession per-patron growth materially outpace IMAX’s per-screen network growth.
• Do not chase an outright IMAX position solely on conference commentary. Set an alert for the next reported system-installation backlog, international box-office collection trend, and forward studio allocations; absent those data, the risk is multiple compression rather than a clearly quantified earnings downgrade.
• Monitor DLB as a watch-list beneficiary rather than a recommended trade: evidence of expanded Dolby Cinema screen commitments or premium-format share gains would support a paired long premium-format basket versus exhibition operators.